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Summary
DNA methylation is an epigenetic modification that plays
a central regulatory role in various biological processes.
Methyl groups are coupled to cytosines by the family of
DNA methyltransferases (DNMTs), where DNMT1 is the
main maintenance enzyme and the DNMT3 branch of the
family is mostly responsible for de novo methylation. The
regulation and function of DNA methylation are dependent
on the genomic and chromatin context, such as binding
sites for transcription factors or the presence of histone
marks. Yet how local context, especially chromatin marks,
influences the recruitment of the different DNMTs to their
genomic target sites remains to be completely revealed.
Elucidating the crosstalk between different histone mod-
ifications and DNA methylation, and their combined ef-
fect on the genome-wide epigenetic landscape, is of par-
ticular interest. Aberrant distribution of chromatin marks
that guide DNMT activity or DNMT mutations that influ-
ence their correct recruitment to the genome have a pro-
found impact on the deposition of DNA methylation, with
consequences for genome function and gene activity. In
this review, we describe the current state of knowledge
on this topic and provide an overview on how chromatin
marks can guide DNMT recruitment in healthy and dis-
eased cells.
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Introduction
While the field of genetics studies heredity, in which genes
that are encoded in the DNA represent the basic units of
inheritance, the field of epigenetics (from the Greek ἐπί,
meaning “above”) studies those mechanisms that effectu-
ate heritable changes without altering the underlying DNA
sequence itself. Such changes are known as epigenetic
modifications and exist in a variety of forms. The only epi-
genetic modification that takes place directly at the lev-
el of the nucleosides is DNA methylation, which compris-
es the coupling of a methyl group (CH3) to DNA bases.
Although other contexts are permissive, most methylation
in vertebrates appears on the 5′ position of the pyrimidine
ring of cytosine, resulting in 5-methylcytosine (5meC) [1].
Apart from a low prevalence of 5meC at CpA, CpT, and
CpC sequences in certain cell types, mammalian cytosine
methylation is generally found in the setting of a cytosine
followed by a guanine on the same strand, constituting a
self-complementary CpG dinucleotide [2, 3]. Due to the in-
herent mutability of 5meC the general occurrence of CpGs
in the genome is low, with the exception of so-called CpG
islands (CGIs), which are short regions of high CpG con-
tent that are commonly associated with gene promoters [4].
Whereas approximately 70% of CpG sites in the adult ver-
tebrate genome are methylated, the majority of CGIs re-
main free from methylation [4]. CGI promoter methyla-
tion can regulate transcription of associated genes in cis,
which is particularly important for X chromosome inac-
tivation, genomic imprinting, and germline-specific genes
[5–7]. In addition, DNA methylation has been shown to
control the silencing of transposable elements [8]. Togeth-
er, this demonstrates that cytosine methylation has a cen-
tral regulatory function in a variety of biological processes.
DNA methylation is a dynamic process, which can be di-
vided into three stages: establishment, maintenance, and
removal. The DNA methyltransferase enzymes DNMT3A
and DNMT3B are the main proteins responsible for de no-
vo methylation; in addition, DNMT3C has recently been
reported to be a rodent-specific methyltransferase that is
involved in silencing young retrotransposons specifically
in the male germline [9], and DNMT3L lacks a functional
catalytic domain but serves as an important cofactor for
DNMT3A and DNMT3B [10]. Representing a different
branch of the DNMT family, DNMT1 is seen as the main
maintenance methyltransferase, which after replication is
recruited to hemimethylated DNA to ensure faithful prop-
agation of methylation patterns [11]. When the activity
of DNMTs is impaired, passive DNA methylation leads
to gradual loss of 5meC over several cell divisions. Al-
ternatively, ten-eleven translocation (TET) methylcytosine
dioxygenases can initiate active DNA demethylation by
catalysing the oxidation of 5meC into 5-hydroxymethylcy-
tosine (5hmC), which subsequently can be processed into
unmethylated cytosine by various means [12, 13]. DNMTs
and TETs are hence the main regulators of the dynamics of
DNA methylation [14, 15].
While promoter methylation has typically been associated
with gene silencing, methylation at gene bodies is in con-
trast positively correlated with transcription, suggesting
that the regulation and function of DNA methylation is
largely context-dependent [2, 16]. Given the global distri-
bution of DNA methylation along the genome, local con-
text is expected to strongly influence how this mark reg-
ulates various biological processes. This context is for a
major part defined by another class of epigenetic modi-
fications, in the form of histone marks. DNA is wrapped
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around an octamer of histone proteins (two of each histone
H2A, H2B, H3, and H4), of which both the core and tail
domains contain a large number of amino acid residues
that can be post-translationally modified. The most impor-
tant and frequently occurring modifications on histones are
methylation and acetylation [17]. Depending on their prop-
erties, different histone modifications, alone or in combi-
nation, could have their own specific effects on transcrip-
tion, leading to the concept that a potential “histone code”
could provide regulatory cues for gene expression. More-
over, numerous studies have investigated the connection
between histone marks and DNA methylation, revealing an
intriguing interplay [18].
In this review, we will address the crosstalk between DNA
methylation and other epigenetic modifications, with a fo-
cus on how histone modifications influence recruitment of
the different DNMT family members to the DNA. In ad-
dition, we will describe several human disease phenotypes
that have been associated with aberrant DNMT recruit-
ment, and what these diseases teach us about the molecular
mechanisms underlying their specific binding.
Recruitment of DNMT1 to the genome
The first member of the DNA methyltransferase family to
be cloned and sequenced in eukaryotes was named DN-
MT1 [19]. DNMT1 is a multi-domain protein consisting
of, from N- to C-terminus, a replication foci targeting se-
quence (RFTS), a zinc finger CXXC domain, two tandem-
ly connected bromo-associated homology (BAH) domains,
and the catalytic methyltransferase (MTase) domain [20]
(fig. 1). Furthermore, its non-catalytic N-terminus has been
revealed to mediate protein-protein interactions [21]. The
preferred substrate for this enzyme was demonstrated to
be hemimethylated DNA, suggesting that it could facilitate
the semi-conservative inheritance of methyl moieties dur-
ing DNA replication [22]. Although DNMT1 is the only
DNA methyltransferase that harbours this substrate speci-
ficity and has therefore been designated as the maintenance
DNMT, it in fact also contains considerable de novo
methylation activity both in vitro and in vivo [23, 24]. Vice
versa, in certain cell types the de novo methyltransferases
DNMT3A and DNMT3B have been shown to contribute to
maintenance methylation as well [25, 26]. While the clas-
sical ‘division of labour’ model of DNMT1 operating in
maintenance and the DNMT3s in de novo methylation still
holds true for certain developmental contexts, it general-
ly is thus an oversimplified, but nevertheless useful frame-
work until all its underlying principles are understood [27,
28].
How DNMT1 is specifically recruited to hemimethylated
DNA has been extensively studied, revealing a complex
mechanism involving several factors. Apart from its inher-
ent preference for hemimethylated cytosine, it was discov-
ered early on that DNMT1 interacts with the DNA clamp
proliferating cell nuclear antigen (PCNA), which localises
at the replication fork and thereby ensures DNMT1 prox-
imity to newly synthesised DNA [29]. However, the later
finding that PCNA is not strictly required for this process
indicated that other players must be involved [30]. The
most important player was subsequently identified to be
the E3 ubiquitin-protein ligase ubiquitin-like with PHD
and RING finger domains 1 (UHRF1), knockout of which
in mice mimics the Dnmt1-/- phenotype [31]. UHRF1 binds
to hemimethylated CpG sites via its SET and RING asso-
ciated (SRA) domain by a base-flipping mechanism, and
engages DNMT1 through a direct protein-protein interac-
tion between its own ubiquitin-like (UBL) domain and the
RFTS of DNMT1 [32, 33]. In addition, UHRF1 binds to
unmodified arginine 2 on histone H3 (H3R2) and to di- and
tri-methylated lysine 9 on histone H3 (H3K9me2/3) via its
plant homeodomain finger (PHD) and tandem tudor do-
main (TTD), respectively, thereby contributing to DNMT1
recruitment to different chromatin environments [34–36].
Recent work suggested also a direct interaction between
H3K9me3 and the RFTS domain of DNMT1, which would
further reinforce the association between this histone mark
and maintenance methylation [37].
Adding another layer of epigenetic complexity, UHRF1
catalyses mono-ubiquitinylation of H3 at lysines 14, 18,
and 23 [38]. These residues are then bound by the RFTS
domain of DNMT1, which is important for both its recruit-
ment as well as its methyltransferase activity [38]. Indeed,
binding of the RFTS to ubiquitylated H3 tails releases its
auto-inhibitory binding to the MTase domain, leading to
enhanced methylation [20]. Recently, an additional ubiq-
uitin-dependent mechanism for DNMT1 recruitment was
proposed, in which UHRF1 ubiquitylates PCNA-associat-
ed factor 15 (PAF15) on chromatin in a DNA replication-
coupled manner [39]. In a mode of action similar to PCNA,
PAF15-Ub2 specifically binds to replicating chromatin and
forms a complex with DNMT1, thereby contributing to
stable maintenance of DNA methylation [39].
Recruitment of the DNMT3 family of proteins
to the genome
In contrast to DNMT1, the DNMT3 branch of the DNMT
family consists of several closely related members, which
in terms of structure represent different variations on the
same theme (fig. 1). DNMT3A and DNMT3B are the
largest proteins and are built up of a relatively long N-
terminal region devoid of any known domains, followed
by three chromatin-interacting domains. From N- to C-ter-
minus these are the proline-tryptophan-tryptophan-proline
(PWWP) domain, the ATRX-DNMT3-DNMT3L (ADD)
domain, and the MTase domain. The rodent-specific DN-
MT3C enzyme arose through duplication of the Dnmt3b
Figure 1: Domain structure of murine DNA methyltransferases.
ADD = ATRX-DNMT3-DNMT3L; BAH = bromo-associated homolo-
gy; MTase = methyltransferase; RFTS = replication foci targeting
sequence
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gene, but during evolution lost its PWWP domain [40].
DNMT3L likewise lost its PWWP domain, and additional-
ly lacks a functional MTase domain, making it the shortest
family member [41]. Although DNMT3L does not possess
any inherent DNA methyltransferase ability, it serves as a
cofactor for DNMT3A and DNMT3B by directly interact-
ing with these proteins and stimulating their activity, which
is particularly important for the establishment and expres-
sion of maternally imprinted genes [10, 42, 43].
DNMT3A and DNMT3B are the main enzymes respon-
sible for setting DNA methylation without pre-existing
methyl groups being present as a template, more com-
monly known as de novo methylation [44]. Despite their
similarity and partial redundancy, neither DNMT3A nor
DNMT3B can fully compensate for the loss of the other
enzyme, indicating their distinctive functionalities [44].
Although it had been known for a long time that DNMT3A
and DNMT3B possess intrinsic affinity for CpG sites,
structural insights into this observation were only recently
obtained [45–49]. These studies present crystal structures
of the catalytic domains of human DNMT3A or DNMT3B
in complex with DNMT3L, providing the structural basis
for CpG-specific de novo DNA methylation.
Furthermore, the observation that DNA methylation is not
evenly distributed over the genome suggests that CpG
binding by the MTase domain is not the only defining fac-
tor for DNMT3 occupancy. Indeed, with the ADD and
PWWP domains DNMT3A and DNMT3B possess two
chromatin-interacting domains that must be taken into ac-
count in this regard. The first indications of the function
of the ADD domain came from peptide interaction assays
that showed that DNMT3L through its N-terminal region
specifically interacts with the tail of histone H3, and that
this interaction is abrogated by methylation of H3K4 [50].
That binding to unmethylated H3K4 is a core function of
the ADD domain that is conserved across the DNMT3
family was subsequently confirmed by studies with DN-
MT3A and DNMT3B [51–53]. Moreover, this finding pro-
vided an explanation for the previously described anti-
correlation between histone H3K4 methylation and DNA
methylation [54, 55]. As shown for DNMT3A, binding
to H3K4me0 by the ADD domain does not only regulate
recruitment, but also stimulates methyltransferase activity
through releasing an autoinhibitory interaction with the
MTase domain [56].
Yet H3K4me3 is not the only histone modification in-
volved in DNMT3 recruitment. Using peptide arrays, it
was shown that the PWWP domain of DNMT3A specif-
ically recognises H3K36me3 [57]. A recent study used
chromatin immunoprecipitation followed by deep se-
quencing (ChIP-seq) and found DNMT3A in vivo to be
predominantly localised in H3K36me2 and H3K36me3
domains, with preferential enrichment in regions with high
H3K36me2 compared to H3K36me3 [58]. This finding
was recapitulated in vitro, with the DNMT3A-PWWP do-
main recognising both H3K36me2 and H3K36me3, but
exhibiting greater affinity for H3K36me2 [58]. Similar in
vivo experiments had already uncovered the targeted re-
cruitment of DNMT3B to H3K36me3-decorated bodies
of transcribed genes [59]. Since both DNMT3C and DN-
MT3L lost their PWWP domain, H3K36 methylation-me-
diated recruitment seems to be specific for DNMT3A and
DNMT3B, although these could in turn recruit the other
DNMTs through protein-protein interactions [40, 41]. In
line with these findings, genome-wide profiling has es-
tablished a positive correlation between H3K36me2/3 and
DNA methylation [58].
Intriguingly, even though H3K36 methylation has been
found to negatively correlate with the repressive histone
mark H3K27me3, the longer isoform of DNMT3A (DN-
MT3A1) was discovered to localise to the H3K27me3-pos-
itive shores of CGIs [60, 61]. Apart from adding another
histone mark to the code defining DNMT3 binding, it
also suggests that more isoform-specific binding patterns
may exist for DNMTs, since this preferential localisation
was not found for the shorter isoform DNMT3A2 [60].
The exact relationship between DNA methylation and
H3K27me3 has as yet remained elusive, but genome-wide
assessments point to an anticorrelation, and indeed
H3K27me3-enriched CGIs have been found to be devoid
of DNA methylation [58, 62]. Rather than a direct recruit-
ing function for H3K27me3, this implies recruitment of
DNMT3A1 through indirect means, the underlying mech-
anisms of which must still be further elucidated.
Other mechanisms of DNMT3 recruitment have addition-
ally been described. For example, the histone methyltrans-
ferase G9a has been demonstrated to recruit DNMT3A and
DNMT3B through a direct interaction with their MTase
domains, thereby connecting H3K9 methylation and de no-
vo DNA methylation [63]. Similarly, the H3K27 histone
methyltransferase EZH2 has been reported to interact with
DNMT1 as well as DNMT3A/B and DNMT3L [64, 65],
although this recruitment was later shown not to be suf-
ficient for de novo DNA methylation and a direct role
for Polycomb group proteins in regulating DNA methyla-
tion remains enigmatic [66–68]. Further protein-protein in-
teractions between DNMT3s and the histone methyltrans-
ferases SUV39H1 and SETDB1 have also been described,
suggesting that the link between histone and DNA methy-
lation may be a more general one [69, 70]. However, it re-
mains to be determined to what extent such connections
would be causative instead of merely correlative.
Aberrant DNMT recruitment in disease
All in all, recruitment of DNMTs is an intricate process
in which the different layers are tightly interwoven. The
robustness ensuing from this multi-layered complexity
points to an imperative function for proper DNMT locali-
sation in healthy individuals; in line with this, mouse em-
bryos homozygous for knockout of the Dnmt1 or Dnmt3b
gene die before birth, while Dnmt3a-/- mutant mice become
runted and die approximately four weeks after birth [44,
71]. Nevertheless, a few diseases in humans have been de-
scribed that could be caused by aberrant DNMT recruit-
ment.
Mutations in the RFTS domain of DNMT1 have been as-
sociated with two different kinds of neurological disorders.
The first one of these is hereditary sensory and autonom-
ic neuropathy type 1 (HSAN1) with dementia and hear-
ing loss, a form of neurodegeneration [72] (table 1). The
identified mutations in DNMT1 were shown to result in
protein misfolding, decreased enzymatic activity, and im-
paired heterochromatin binding, leading to the disease phe-
notype. On the level of the methylome, this translates to
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moderate global hypomethylation of cytosines but local
hypermethylation at CGIs [72]. The second disease caused
by mutations in the DNMT1-RFTS domain is autosomal
dominant cerebellar ataxia, deafness and narcolepsy (AD-
CA-DN) [73] (table 1). Interestingly, both conditions are
characterised by a late onset, proposing an important role
for correct DNA maintenance methylation recruitment in
adult neurons.
Regarding the DNMT3 family, aberrant recruitment of
mostly DNMT3A has been implicated in disease. Muta-
tions in the DNMT3A gene have been widely associated
with various haematological malignancies, most frequently
with acute myeloid leukaemia (AML), but also including
T-cell acute lymphoblastic leukaemia (T-ALL), chronic
myelomonocytic leukaemia (CMML), and myelodysplas-
tic syndrome (MDS) [74, 75] (table 1). In addition, DN-
MT3A mutations have been found to cause age-related
clonal haematopoiesis (ARCH), which has been associated
with not only haematological but also cardiovascular dis-
ease [76, 77] (table 1). Although one clear mutational
hotspot exists at R882 in the MTase domain, disease-caus-
ing mutations have been found to occur over the entire
length of the gene, leading to reduced methyltransferase
activity, but also decreased or enhanced DNA binding, or
impaired ability to multimerise on the DNA. The exact
mechanisms by which these mutations drive haematologi-
cal disease remain to be clarified but are often associated
with genome-wide changes in the DNA methylation land-
scape. Through as yet unknown pathways this influences
the cells’ ability to switch from self-renewal to differentia-
tion, resulting in various kinds of neoplasms [74].
Furthermore, DNMT3A mutations have been linked to ab-
normal growth phenotypes. In the Tatton-Brown-Rahman
syndrome, loss-of-function mutations in DNMT3A cause
an overgrowth condition paired with mild to moderate in-
tellectual disability [78] (table 1). Interestingly, these mu-
tations are distributed over the PWWP, ADD, and MTase
domains, but do not appear in the N-terminal stretch or
the regions in between the domains. This suggests that
they could interfere with the binding to histone modifica-
tions, domain-domain interactions, or both [78]. Recipro-
cally, recent studies linked gain-of-function mutations in
the PWWP domain of DNMT3A to growth retardations
[79, 80] (table 1). Whole-exome sequencing of micro-
cephalic dwarfism patients identified two different de novo
mutations, affecting two amino acids (W330R and D333N)
that are part of the aromatic cage that forms around the
methylated lysine 36 on histone H3 [82]. Mouse models
carrying the murine equivalents of these mutations
(W326R and D329A, respectively) displayed growth
deficits as demonstrated by reduced brain size and body
weight, recapitulating the human disease phenotype [79,
80]. On the molecular level, W326R and D329A were
shown in in vitro experiments to impair binding of the
PWWP domain to H3K36me2/3, suggesting altered bind-
ing specificity of DNMT3A to the DNA [57, 79]. Indeed,
genome-wide assessment of DNA methylation in two mi-
crocephaly patient-derived fibroblast lines identified 1878
common differentially methylated regions (DMRs), the
majority of which was hypermethylated relative to healthy
controls [79]. Such hypermethylated DMRs were frequent-
ly positioned close to key developmental gene loci that
were associated with Polycomb-mediated repression in
control cells, but showed reduced levels of H3K27me3 in
patient fibroblasts [79]. Similar results were obtained by
genome-wide DNA methylation profiling in several tis-
sues of adult Dnmt3aΔ/D329A mice [80]. Counterintuitively,
increased DNA methylation at these sites leads to de-re-
pression of the associated genes, possibly through dis-
placement of the repressive Polycomb complexes [80].
Interestingly, gain-of-function mutations in the PWWP do-
main of DNMT3A have also been found in patients with
paraganglioma, a type of neuroendocrine tumours [81]
(table 1). CRISPR/Cas9-mediated introduction of one of
these mutations (K299I) in HeLa cells caused genome-
wide alterations in the DNA methylation landscape, sug-
gesting that aberrant DNMT3A recruitment through mu-
tations in the PWWP domain may be a more general
disease-causing event [81].
Although DNMT3B is much less implicated in human dis-
ease, mutations in the DNMT3B gene are well described
to cause ICF syndrome, a rare autosomal recessive disease
that is characterised by immunodeficiency, centromeric in-
stability, and facial anomalies [83] (table 1). These muta-
Table 1: Diseases associated with aberrant DNMT recruitment.
Disease Gene Mutations Molecular effect References
HSAN1 (hereditary sensory and autonomic neu-
ropathy type 1 with dementia and hearing loss)
DNMT1 Y495C
D490E-P491Y
Protein misfolding, decreased enzy-
matic activity, and impaired hete-
rochromatin binding
[72]





Not tested, but hypothesised altered
DNA binding and/or protein-protein
interactions
[73]
Various haematological malignancies (AML, T-ALL,
CMML, MDS, ARCH)
DNMT3A Hotspot at R882; other disease-
causing mutations over the en-
tire length of the gene
Reduced methyltransferase activity,
decreased or enhanced DNA bind-
ing, impaired ability to multimerise on
the DNA, etc.
[74–77]





Not tested, but hypothesised altered
binding to histone modifications and/
or domain-domain interactions
[78]




Not tested, but hypothesised abro-
gated H3K36me2/3 interaction
[81]
ICF syndrome (immunodeficiency, centromeric in-
stability, and facial anomalies)
DNMT3B Several in both the MTase and
PWWP domain, e.g. S282P
Abrogated H3K36me3 interaction [59, 82–84]
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tions have been found not only in the MTase domain, but
also in the PWWP domain; one of which (S282P in hu-
man, S277P in mouse) was shown by ChIP-seq to abrogate
interaction with H3K36me3 [59, 84]. A crystallography
study subsequently revealed that this residue stabilises the
interaction between methylated H3K36 and a conserved
water molecule, building a strong hydrogen bond that is
needed for DNMT3B-PWWP substrate recognition [82].
This indicates that H3K36me3-mediated DNMT3B re-
cruitment is essential for healthy cell function.
Future directions
Recruitment of DNMTs to their genomic target sites is a
multifaceted process that is dependent on various epigenet-
ic events, which both directly and indirectly contribute to
the establishment and maintenance of the DNA methyla-
tion landscape. Many such contributing factors have been
described, providing important insights into the underlying
mechanisms, but at the same time leaving many questions
unanswered. Indeed, further research is needed to address
these outstanding issues and help construct a complete pic-
ture.
For DNMT1, the main histone modifications influencing
its recruitment are H3R2, H3Ub, and H3K9me2/3. Not
much is known about the gene-regulatory effect of H3R2,
methylation of which has been reported to be either asso-
ciated with euchromatin, or with heterochromatin through
antagonising H3K4me3 [85, 86]. The role of H3Ub in tran-
scriptional regulation is likewise not well characterised. In
contrast, H3K9 methylation has been studied in more de-
tail, revealing a link to repressed chromatin such as cen-
tromeres, transposons, repetitive elements, and imprinted
loci [87]. H3K9me2/3 recognition by UHRF1 and subse-
quent DNMT1 recruitment or by DNMT1 itself thus pro-
vides a clear connection between this histone mark and
DNA methylation at heterochromatic regions, whose coop-
erative effect is gene silencing.
The most important players influencing DNMT3 recruit-
ment are H3K4 methylation, H3K27me3, and H3K36me2/
3 (fig. 2). H3K4 methylation is a marker for regulatory
regions, with H3K4me1 designating enhancers and
H3K4me3 promoters [88]. As such, H3K4me3 is enriched
at CGIs and anticorrelates with DNA methylation [87]. In-
terestingly, a subset of CGI promoters is decorated with
the activating H3K4me3 and the repressive H3K27me3 hi-
stone marks at the same time. This combination has been
termed ‘bivalent’, and is believed to ready key develop-
mental genes for rapid activation or repression in a lineage-
specific manner [87]. The presence of H3K27me3 by itself
is associated with silencing and high levels of CpG methy-
lation throughout most of the genome [62, 88]. At CGIs,
however, H3K27me3 and DNA methylation are mutual-
ly exclusive, providing an explanation for the unmethylat-
ed status of bivalent promoters. Upon global reduction of
DNA methylation, H3K27me3 peaks at these sites flatten
and spread out, leading to an altered 3D genome through
the loss of Polycomb-mediated distal interactions and sug-
gesting that DNA methylation serves to restrict
H3K27me3 domains at CGIs [62, 89–91]. The molecular
mechanisms behind this redistribution of H3K27me3 in the
absence of DNA methylation are hitherto unknown, and al-
so the biological consequences remain an active area of in-
vestigation. Additionally, much remains unclear about the
role of H3K27me3 in recruiting the DNMT3s, and DN-
MT3A in particular. To our current knowledge, no domain
or region responsible for H3K27me3 recognition has been
identified in any of the DNMT3 proteins, arguing against
a direct interaction through substrate binding. The fact that
the co-occurrence of H3K27me3 and DNA methylation is
context-dependent likewise points to more indirect path-
ways. Future research should therefore investigate which
players could constitute the missing link between
H3K27me3 and DNMT recruitment.
While H3K4me3 and H3K27me3 are important regulators
for DNMT3 localisation at CGIs, H3K36me2/3 is strongly
Figure 2: Histone tail modifications influencing DNMT3A/B recruitment to DNA. The PWWP domain recognises H3K36me2/3 (blue triangles),
while the ADD domain is repelled by H3K4me3 (yellow stars). Additionally, the ADD domain auto-inhibits the MTase domain. How H3K27me3
(pink pentagon) influences DNMT3A/B recruitment remains to be elucidated. TSS = transcription start site
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enriched across the transcribed bodies of active genes [87].
Both H3K36me2 and H3K36me3 positively correlate with
DNA methylation, supporting their function in recruiting
DNMT3A and DNMT3B, respectively [58, 59]. Recent
studies described mutations in the PWWP domain of DN-
MT3A that abrogate H3K36 binding, instead recruiting
this protein to chromatin that is marked with H3K27me3
in wildtype cells [79, 80]. Previous research had reported
that such lowly methylated H3K27me3-marked regions
are more likely to contract in the absence of DNMT3A,
strengthening the notion that there is crosstalk between
DNA methylation and H3K27me3 [92]. Whether this re-
cruitment of mutated DNMT3A is specific or rather a gen-
eral consequence of increased protein availability is still
an open question, the answer to which will teach us more
about the dynamics between H3K36me2/3 and H3K27me3
in instructing DNA methylation patterns.
Although recent research has significantly improved our
structural understanding of the above-mentioned molecu-
lar mechanisms underlying DNMT recruitment, some im-
portant information is still missing. Since all structures of
DNMT1 that are currently available have been obtained
using truncated proteins, the exact domain arrangement of
the full-length protein may not have been properly reca-
pitulated [93]. This is especially relevant since interactions
between different domains exist that influence the function
of the protein, most notably the auto-inhibitory binding
of the RFTS domain to the MTase domain [20]. For DN-
MT3A and DNMT3B it would likewise be useful to com-
pare different stretches of the proteins, which would pro-
vide information not only on the function of the domains
by themselves or in combination, but also on the natural-
ly occurring isoforms. Additionally, advances in Cryo-EM
could help to obtain novel mechanistic insights into DN-
MT function in the presence of their natural binding sub-
strates of reconstituted nucleosomes carrying distinct mod-
ifications.
Furthermore, it would be informative to compare struc-
tures of the DNMTs interacting with other family mem-
bers. Apart from interactions within the DNMT3 branch,
DNMT3s are also known to interact with DNMT1 [94],
yet if and how these interactions influence conformation
and subsequent DNA binding as well as biological func-
tion remains to be determined. Such insights could in turn
also shed light on the observation that different DNMT3
family members, but also protein isoforms, show differen-
tial DNA binding patterns [59, 60]. Besides recruitment of
DNMTs to specific chromatin states, recent work suggest-
ed structural differences in substrate recognition that could
contribute to differential DNMT3A/B activities based on
flanking-DNA-sequence around the methylated cytosine
[47–49]. Such DNA sequence-mediated differences could
strongly contribute to global DNA methylation patterns
and provide an additional layer of DNMT regulation,
which should be further explored. Some hypotheses on
this topic can nonetheless already be formulated based on
our current knowledge, for example concerning the DN-
MT3A/B-DNMT3L interaction. As described, DNMT3L
contributes to H3K4me0 binding through its ADD domain,
but because of its lacking PWWP domain by definition
cannot recognise H3K36 methylation [50]. We can there-
fore hypothesise that interaction with DNMT3L could
strengthen the affinity of DNMT3A or DNMT3B for
H3K4me0, while methylation of H3K36 may be less im-
portant. It would be interesting to investigate whether the
methylation status of H3K4 is indeed more instructive for
DNA methylation patterns than that of H3K36, and if this
is correlated to the expression of DNMT3L.
All in all, although various pathways influencing DNMT
recruitment to DNA have been charted, how exactly they
should be navigated remains to be determined. Dissecting
these mechanisms will aid our understanding of the
crosstalk between different histone modifications and
DNA methylation, and how this together influences the
genome-wide epigenetic landscape. Yet this is still only
part of the whole story, since factors like protein-protein
interactions, post-translational modifications, and RNAs
have also been described to be involved in recruiting DN-
MTs to their genomic target loci [93]. In addition to mech-
anisms that recruit DNMTs to the genome, allosteric regu-
lation [93] and structural constrains that influence catalytic
activity based on DNA sequence context [47, 95, 96] are
expected to contribute to DNA methylation regulation.
Continued efforts will be directed towards solving this in-
triguing puzzle.
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